Clinical Trial Update: A Study of a New Type of Insulin in Participants With Type 1 Diabetes on Insulin Injection Therapy [Phase 1]

View source ↗

Summary

Phase 1 study of a new insulin analogue in participants with Type 1 diabetes on insulin injection therapy has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• Investigational insulin analogue (Phase 1) (insulin analogue)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Diabetes Mellitus, Type 1 | Phase 1 | Status: WITHDRAWN